What is Liraglutide? Learn About Its Uses, Dosage & Side Effects
Discover what liraglutide is, how it works for diabetes and weight loss, its side effects, and how it compares to newer drugs like semaglutide.
Learn how liraglutide works for diabetes and weight management. Discover its side effects, dosing, and cost-saving tips.
Liraglutide works by slowing gastric emptying and increasing satiety. It is a human glucagon-like peptide-1 (GLP-1) receptor agonist and antidiabetic medication prescribed for weight management and type 2 diabetes.
Liraglutide mimics the actions of the body's naturally occurring hormone that helps regulate blood glucose levels. It stimulates insulin secretion and lowers glucagon secretion when blood glucose levels are high by binding to and activating the GLP-1 receptor.
Liraglutide is a GLP-1 receptor agonist used to manage weight and treat type 2 diabetes in adults.
The medication is effective at lowering blood glucose levels, reducing body weight, and is sold under two brand names:
Both versions work similarly but have different dosing guidelines and indications.
In adults with type 2 diabetes and heart disease, liraglutide may reduce the risk of heart attacks and strokes.
Liraglutide is also available in a compounded version. Compounded GLP-1 medications contain the same active ingredient as the FDA-approved GLP-1 drugs.
Compounded versions can also include added ingredients like vitamins or other medications. They are prepared in compounding pharmacies and require a prescription.
{{primary-cta}}
Liraglutide mimics the GLP-1 hormone, which regulates appetite, digestion, and blood sugar. Here’s how it impacts your body:
Result: Liraglutide addresses multiple pathways and helps lower blood sugar (for diabetes) and manage chronic weight (for obesity).
Key Tips:
Most GLP-1 side effects are mild and improve within weeks.
Liraglutide isn’t safe for everyone. Avoid it if you:
Drug Interactions:
{{primary-cta}}
Liraglutide was one of the first GLP-1 drugs, but now there are newer options like semaglutide (Wegovy®, Ozempic®). When comparing liraglutide vs semaglutide, you’ll see that semaglutide offers:
Liraglutide remains a cost-effective choice for patients who:
Without insurance, liraglutide can cost between $469–$1,500/month. Here’s how you may be able to save:
Eden is committed to making weight loss care accessible:
Safe and simple: Your health and well-being are Eden's top priority. Medications are delivered from a state-licensed pharmacy in network, right to your door when you need them.
Start your consultation today or explore Eden’s GLP-1 resources for more guides.
Liraglutide’s ability to mimic the GLP-1 hormone makes it a valuable tool for tackling obesity and type 2 diabetes. By curbing appetite, stabilizing blood sugar, and promoting gradual weight loss, it addresses the root causes of these chronic conditions.
Its effectiveness is based on consistent use, medical supervision, and pairing it with sustainable lifestyle changes like diet and exercise. While side effects like nausea are common, most patients adapt over time, and the long-term benefits often outweigh initial discomforts.
If you’re considering liraglutide, consult a healthcare provider to discuss whether it aligns with your health profile and goals. Eden is here to help you navigate liraglutide treatment options and cost-saving strategies—because understanding how a medication works is the first step toward making it work for you.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Some patients may notice weight loss or blood sugar improvements may start within 2–4 weeks, but full effects may take 8–12 weeks.
No. Saxenda (3.0 mg) and Victoza (1.8 mg) have different dosing protocols. Always follow your prescription.
It's possible. Obesity is a chronic condition, and stopping medication may lead to weight regain.
No—it helps manage blood sugar but isn’t a cure. Pair it with diet, exercise, and monitoring.
Novo Nordisk. (n.d.). Explaining the list price of Saxenda (liraglutide). NovoCare. Retrieved from https://www.novocare.com/obesity/products/saxenda/explaining-list-price.html
Novo Nordisk. (n.d.). Victoza® support and savings. Victoza. Retrieved from https://www.victoza.com/victoza-support-and-savings.html
SCALE Diabetes Trial (2015). Pi-Sunyer, X., et al. "Liraglutide 3.0 mg for Weight Management in Overweight or Obese Adults With Type 2 Diabetes." JAMA Network, 2015. jamanetwork.com
Nauck, M.A., et al. (2021). "Efficacy and Safety Comparison of Semaglutide and Liraglutide in Type 2 Diabetes: A Systematic Review." Diabetes, Obesity and Metabolism, 23, 701-711. https://doi.org/10.1111/dom.14270
STEP 8 Trial (2022). Wilding, J.P.H., et al. "Effect of Weekly Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes." JAMA Network, 2022. jamanetwork.com
U.S. Food and Drug Administration. (2024). FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss?utm_source=chatgpt.com.
LEADER Trial (2016). Marso, S.P., et al. "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes." New England Journal of Medicine, 375, 311-322. https://www.nejm.org/doi/full/10.1056/NEJMoa1603827